A Clinical Study On the Role of Vamana and Virechana in the management of Hypothyroidism with Punarnava Amruta Guggulu
试验速览
- 阶段
- 1/2 期
- 状态
- 招募中
- 发起方
- 入组人数
- 45
- 试验地点
- 1
- 主要终点
- The efficacy of treatment will be assessed on the basis of relief in signs and symptoms Evaluation of BIOCHEMICAL parameters such as serum TSH serum T3 and T4 in all groups with Hematological Urine routine and microscopic examination before and after treatment
研究概览
简要总结
The present study is designed with the aims to study to evaluate the efficacy of Vamana karma in the management of Hypothyroidism, to study to evaluate the efficacy of Virechana karma in the management of Hypothyroidism after this as shamana drug PUNARANAVA AMRUTA GUGGULU in both groups and group C is controle with tablet Levothyroxine sodium
IN GROUP A VAMANA KARMA
Deepan pachana Trikatu churna 2g TDS with luke warm water 3-7days
Snehpan Go ghrita as per Koshtha 3-7days
Abhyanga and Swedana Bala oil 2 times a day 1day
vamana yoga(1day) Madanphalapippali 6-10g
Vacha churna 2-5g
Saidhava 5-10g
Honey 50ml
Yastimadhu phant 2-3 Liter
samsarjana karma Diet (as per shuddhi) 3-7days
IN GROUP B VIRECHANA KARMA
Deepan pachana(as
Snehpana(as above)
Abhyanga Swedana Bala oil 3days
Virechana yoga(1 day) Trikatu churna 2g
Triphala churna 5g
Danti churna 10g
Trivritta churna 10g
Chitraka churna 1g
Snuhikshira 10ml
Gudodaka 40-80ml
Samsarjana karma (as per shuddhi) 3-7 days
Internal Shamana yoga :Punaranava amruta guggulu 1g tds(2 tablets each 500mg) ANUPAN:Luke warm water 45 days
GROUP C : Standered controle Tab Levothyroxine sodium dose :as per physician prescribe 45 days
CRITERIYA FOR ASSESSMENT:
The efficacy of treatment will be assessed on the basis of relief in signs and symptoms
On the basis of changes in the laboratory investigation
Status of Dosha,Dushya and Agni will be assessed before after treatment
FOLLOW UP:
Follow up will be done for four weeks after the complition of****treatment to see the long standing effect of the treatment.
Patients will be redirected to regular OPD treatment after the stipulated time of research work.
研究设计
- 研究类型
- Interventional
- 分配方式
- Coin toss, Lottery, toss of dice, shuffling cards etc
- 盲法
- Open Label
入排标准
- 年龄范围
- 20.00 Year(s) 至 60.00 Year(s)(—)
- 性别
- All
入选标准
- •Patients with clinical features of Hypothyroidism namely increase level of serum TSH decrease level of serum T3 serum T4 irregular menstruation weakness fatigue weight gain hair fall constipation puffiness of face bilateral peripheral edema dry and coarse skin palpitation cold intolerance lethargy.
排除标准
- •Patients with Ischemic heart diseases Uncontrolled hypertension Myocardial infarction Cardiovascular event Cardiac arrhythmia Pregnancy Active malignant disease.
结局指标
主要结局
The efficacy of treatment will be assessed on the basis of relief in signs and symptoms Evaluation of BIOCHEMICAL parameters such as serum TSH serum T3 and T4 in all groups with Hematological Urine routine and microscopic examination before and after treatment
时间窗: 60 Days in two interventional group A B and 45 Days in Controle group
次要结局
- Exacerbation in signs and symptoms(4 Weeks)
